Cara Therapeutics to Present at the the 2021 Cantor Virtual Global Healthcare Conference
September 24 2021 - 7:00AM
Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical
company focused on developing and commercializing new chemical
entities designed to alleviate pruritus by selectively targeting
peripheral kappa opioid receptors (KORs), today announced that
Derek Chalmers, Ph.D., D.Sc., President and Chief Executive
Officer, will participate in a fireside chat at the 2021 Cantor
Virtual Global Healthcare Conference on Tuesday, September 28, 2021
at 3.20 p.m. ET.
A live webcast of the fireside chat can be
accessed under "Events & Presentations" in the News &
Investors section of the Company's website
at www.CaraTherapeutics.com. An archived webcast recording
will be available on the Cara website for approximately 30
days.
About Cara TherapeuticsCara
Therapeutics is a clinical-stage biopharmaceutical company focused
on developing and commercializing new chemical entities designed to
alleviate pruritus by selectively targeting peripheral kappa opioid
receptors, or KORs. Cara is developing a novel and proprietary
class of product candidates, led by KORSUVA™ (CR845/difelikefalin),
a first-in-class KOR agonist that targets the body’s peripheral
nervous system, as well as certain immune cells. KORSUVA Injection
was approved by the U.S. Food and Drug Administration (FDA) for the
treatment of moderate-to-severe pruritus associated with chronic
kidney disease (CKD-aP ) in adults undergoing hemodialysis on
August 23, 2021. Oral KORSUVA has completed Phase 2 trials for the
treatment of pruritus in patients with CKD and atopic dermatitis
and is currently in Phase 2 trials in primary biliary cholangitis
and notalgia paresthetica patients with moderate-to-severe
pruritus.
MEDIA CONTACT:Claire LaCagnina6
Degrees315-765-1462clacagnina@6degreespr.com
INVESTOR CONTACT:Janhavi MohiteStern Investor
Relations, Inc.212-362-1200janhavi.mohite@SternIR.com
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Sep 2023 to Sep 2024